Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murali Gopalakrishnan

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.
Journal of Medicinal Chemistry|November 2, 2007
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Michael E Brune, Steven A Buckner, et al.
Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
Pain|June 20, 2006
(L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in ratsJames J Lynch, Prisca Honore, David J Anderson, et al.
Frontiers in Genetics|November 1, 2012
AhR activation underlies the CYP1A autoinduction by A-998679 in ratsMichael J Liguori, Chih-Hung Lee, Hong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Structure-activity relationship of a novel class of naphthyl amide KATP channel openersSean C Turner, William A Carroll, Tammie K White, et al.
European Journal of Pharmacology|June 12, 2016
A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injuryChang Z Zhu, Sujatha Gopalakrishnan, Kelly Doyle, et al.
Journal of Neuroscience Methods|July 5, 2011
KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channelsDi Zhang, Rama Thimmapaya, Xu-Feng Zhang, et al.
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.
Journal of Medicinal Chemistry|November 2, 2007
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Michael E Brune, Steven A Buckner, et al.
Journal of Cardiovascular Pharmacology|July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogsRyan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
Pain|June 20, 2006
(L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in ratsJames J Lynch, Prisca Honore, David J Anderson, et al.
Frontiers in Genetics|November 1, 2012
AhR activation underlies the CYP1A autoinduction by A-998679 in ratsMichael J Liguori, Chih-Hung Lee, Hong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Structure-activity relationship of a novel class of naphthyl amide KATP channel openersSean C Turner, William A Carroll, Tammie K White, et al.
European Journal of Pharmacology|June 12, 2016
A-306989, an inhibitor of adenosine kinase, is renoprotective in rodent models of podocyte, basement membrane, and obstructive injuryChang Z Zhu, Sujatha Gopalakrishnan, Kelly Doyle, et al.
Journal of Neuroscience Methods|July 5, 2011
KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channelsDi Zhang, Rama Thimmapaya, Xu-Feng Zhang, et al.
Molecular Pharmacology|June 20, 2003
[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of bindingRachel Davis-Taber, Eduardo J Molinari, Robert J Altenbach, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.
Pageof 9